ROSEMIQUE PIERRE: Open Payments
NPI 1033898390 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $336 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $225 |
| Braeburn Inc. | 1 | $134 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 1 | $97 |
| Phathom Pharmaceuticals, Inc. | 1 | $96 |
Products named: VRAYLAR, BRIXADI, UZEDY, INVEGA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
